WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Earnings & Revenue

AGIO past revenue growth

How has AGIO's revenue growth performed historically?
Company
88.36%
Industry
165.61%
Market
17.84%
AGIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AGIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AGIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AGIO earnings and revenue history

Current Revenue
$26.8M
Current Earnings
-$352.1M
Current Profit Margin
-1,312.6%

AGIO Return on Equity

Current Company
-38.1%
Current Industry
-63.6%
Current Market
188%
AGIO's Return on Equity (-38.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AGIO announces earnings.

AGIO Return on Assets

Current Company
-33.7%
Current Industry
3%
AGIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AGIO Return on Capital Employed

Current Company
-40.51%
Current Industry
19.6%
AGIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AGIO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AGIO$26.82M-$334.75M-$352.09M-22.25%N/A
INBX$1.80M-$206.56M-$241.36M-26.85%N/A
KURA$0.00-$150.23M-$152.63MN/AN/A
VCYT$361.05M-$45.27M-$74.40M+31.45%N/A
PTGX$60.00M-$75.64M-$78.96M+14.17%N/A

AGIO earnings dates

Next earnings date
May 2, 2024

Agios Pharmaceuticals Earnings & Revenue FAQ

What were AGIO's earnings last quarter?

On Invalid Date, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q4 2023 earnings per share (EPS) of -$1.72, up 356.72% year over year. Total Agios Pharmaceuticals earnings for the quarter were -$95.94 million. In the same quarter last year, Agios Pharmaceuticals's earnings per share (EPS) was $0.67.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.

What was AGIO's earnings growth in the past year?

As of Q1 2024, Agios Pharmaceuticals's earnings has grown year over year. Agios Pharmaceuticals's earnings in the past year totalled -$352.09 million.

What is AGIO's earnings date?

Agios Pharmaceuticals's earnings date is Invalid Date. Add AGIO to your watchlist to be reminded of AGIO's next earnings announcement.

What was AGIO's revenue last quarter?

On Invalid Date, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q4 2023 revenue of $7.10 million up 64.8% year over year. In the same quarter last year, Agios Pharmaceuticals's revenue was $4.31 million.

What was AGIO's revenue growth in the past year?

As of Q1 2024, Agios Pharmaceuticals's revenue has grown 88.36% year over year. This is 77.25 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Agios Pharmaceuticals's revenue in the past year totalled $26.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.